¼¼°èÀÇ Á¶Á÷°øÇÐ ÇǺΠ´ëü¹° ½ÃÀå
Tissue Engineered Skin Substitutes
»óǰÄÚµå : 1595054
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 89 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,171,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,515,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Á¶Á÷°øÇÐ ÇǺΠ´ëü¹° ½ÃÀåÀº 2030³â±îÁö 54¾ï ´Þ·¯¿¡ µµ´Þ

2023³â¿¡ 31¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ Á¶Á÷°øÇÐ ÇǺΠ´ëü¹° ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2023-2030³â¿¡ CAGR 8.2%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 54¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ »ý¹°ÇÐÀû ´ëü¹°Àº CAGR 8.8%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 29¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇÕ¼º ´ëüǰ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 8.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 8¾ï 5,300¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Á¶Á÷°øÇÐ ÇǺΠ´ëü¹° ½ÃÀåÀº 2023³â¿¡ 8¾ï 5,300¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2023-2030³â CAGR 7.6%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â 8¾ï 2,250¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 7.6%¿Í 6.6%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 6.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Á¶Á÷°øÇÐ ÇǺΠ´ëü¹° ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Á¶Á÷°øÇÐ ÇǺΠ´ëü¹°Àº â»ó°ü¸®¿¡ ¾î¶² Çõ¸íÀ» ÀÏÀ¸Å°°í Àִ°¡?

Á¶Á÷°øÇÐ ÇǺΠ´ëü¹°Àº ÁßÁõ È­»ó, ¸¸¼º â»ó, ±âŸ ÇǺΠ¼Õ»óÀ» ÀÔÀº ȯÀÚÀÇ ¼Õ»óµÇ°Å³ª ¼Õ½ÇµÈ ÇǺΠÁ¶Á÷À» ´ëüÇϱâ À§ÇØ °í¾ÈµÈ ÷´Ü »ýü Àç·áÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ´ëü¹°Àº »ýü ÀûÇÕ¼º ½ºÄ³Æúµå, ¼¼Æ÷ ¹× ¼ºÀå ÀÎÀÚ¸¦ »ç¿ëÇÏ¿© °³¹ßµÇ¾î ÀÚ¿¬ ÇǺÎÀÇ ±¸Á¶¿Í ±â´ÉÀ» ¸ð¹æÇÏ¿© ´õ ºü¸¥ Ä¡À¯¸¦ ÃËÁøÇϰí ÈäÅ͸¦ °¨¼Ò½Ãŵ´Ï´Ù. µ¿Á¾ À̽Ä, ÀÚ°¡ À̽Ä, ÀÌÁ¾ À̽ÄÀ¸·Î Á¦°øµÇ´Â Á¶Á÷°øÇÐ ÇǺΠ´ëü¹°Àº Àç°Ç ¼ö¼ú, ÇǺΰú ¹× »óó °ü¸®¿¡ ÇʼöÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ È¯ÀÚÀÇ ¿¹ÈÄ °³¼±°ú Á¶±â ȸº¹À» Áß½ÃÇÏ´Â °¡¿îµ¥, Á¶Á÷°øÇÐ ÇǺΠ´ëü¹°Àº ±âÁ¸ ÇǺΠÀ̽ÄÀ» ´ëüÇÒ ¼ö ÀÖ´Â È¿°úÀûÀÎ ´ë¾ÈÀ¸·Î °¢±¤¹Þ°í ÀÖ½À´Ï´Ù.

Á¶Á÷°øÇÐ ÇǺΠ´ëü¹° ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº?

ÁÖ¿ä Á¦Ç° À¯Çü¿¡´Â ¼¼Æ÷ ´ëü¹°, ¼¼Æ÷ ´ëü¹°, º¹ÇÕ ´ëü¹°ÀÌ ÀÖ½À´Ï´Ù. ÁÖ·Î Äݶó°Õ ¹× ±âŸ »ýü Àç·á·Î ¸¸µç ¼¼Æ÷ ´ëü¹°Àº È­»ó Ä¡·á ¹× ¸¸¼º »óó °ü¸®¿¡ ³Î¸® »ç¿ëµÇ¹Ç·Î Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. »ì¾ÆÀÖ´Â ¼¼Æ÷¸¦ Æ÷ÇÔÇÏ´Â ¼¼Æ÷ ´ëü¹°Àº ȯÀÚÀÇ ÇÇºÎ¿Í ÅëÇյǾî Ä¡À¯¸¦ ÃËÁøÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. Á¶Á÷°øÇÐ ÇǺΠ´ëü¹°ÀÇ ¿ëµµ¿¡´Â È­»ó °ü¸®, ´ç´¢¼º ±Ë¾ç, ¿åâ, Àç°Ç ¼ö¼ú µîÀÌ Æ÷ÇԵǸç, È­»ó °ü¸®´Â ÁßÁõ ȯÀÚ¿¡¼­ ºü¸¥ ÇǺΠÀç»ýÀÌ ¸Å¿ì Áß¿äÇϹǷΠ°¡Àå Å« ºñÁßÀ» Â÷ÁöÇÕ´Ï´Ù. Á¶Á÷°øÇÐ ÇǺΠ´ëü¹°ÀÇ ÃÖÁ¾»ç¿ëÀÚ¿¡´Â º´¿ø, »óó Ä¡·á ¼¾ÅÍ, Àü¹® Ŭ¸®´Ð µîÀÌ Æ÷ÇԵ˴ϴÙ. º´¿øÀº ½ÃÀåÀ» ¼±µµÇϰí ÀÖÀ¸¸ç, È­»ó Ä¡·á, Àç°Ç ¼ö¼ú, ¸¸¼º »óó °ü¸® µî ºü¸¥ Ä¡À¯¿Í ÀÔ¿ø ±â°£ ´ÜÃàÀÌ Áß¿äÇÑ °æ¿ì¿¡ ÀÌ·¯ÇÑ ´ëüÀ縦 »ç¿ëÇϰí ÀÖ½À´Ï´Ù. »óó Ä¡·á ¼¾ÅÍ´Â ´ç´¢º´¼º ±Ë¾ç, ¿åâ ¹× ±âŸ Ä¡À¯µÇÁö ¾Ê´Â »óó¸¦ Ä¡·áÇϱâ À§ÇØ ÇǺΠ´ëü¹°À» »ç¿ëÇÏ¿© ȯÀÚÀÇ È¸º¹À» °³¼±ÇÏ°í °¨¿° À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ¶ÇÇÑ Àü¹® Ŭ¸®´Ð¿¡¼­´Â ¹Ì¿ë ¼ºÇü ¹× Àç°Ç ¼ö¼ú¿¡ ÀÌ·¯ÇÑ ´ë¿ëǰÀ» »ç¿ëÇÏ¿© ´õ ³ªÀº ¹ÌÀû °á°ú¿Í ´õ ºü¸¥ ȸº¹ ½Ã°£À» ´Þ¼ºÇÕ´Ï´Ù.

Á¶Á÷°øÇÐ ÇǺΠ´ëü¹°Àº ¾î¶»°Ô ÇコÄɾ Àû¿ëµÇ°í Àִ°¡?

º´¿ø¿¡¼­ Á¶Á÷°øÇÐ ÇǺΠ´ëü¹°Àº ½ÉÇÑ È­»ó, ±íÀº »óó, ¼ö¼ú ÈÄ È¸º¹¿¡ »ç¿ëµÇ¾î ºü¸¥ Ä¡À¯¸¦ ÃËÁøÇϰí ÈäÅÍ Çü¼ºÀ» ÃÖ¼ÒÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. »óó Ä¡·á ¼¾ÅÍ¿¡¼­´Â ´ç´¢º´¼º ±Ë¾çÀ̳ª ¿åâ°ú °°Àº ¸¸¼º »óó °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, ÇǺΠÁ¶Á÷ Àç»ý°ú °¨¿°À» ¿¹¹æÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. Àç°Ç ¹× ¹Ì¿ë ¼ö¼ú¿¡¼­ ÇǺΠ´ëü¹°Àº ƯÈ÷ ¿Ü»ó, ¼±ÃµÀû °á¼Õ, ¾Ï ¼ö¼ú ÈÄ µîÀÇ °æ¿ì¿¡ ½É¹ÌÀû ȸº¹°ú ÇǺΠ±â´É °³¼±¿¡ µµ¿òÀ» ÁÝ´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ÇǺΠ´ëü¹°¿¡ ÷´Ü »ýü Àç·á¸¦ »ç¿ëÇÏ¸é ±âÁõÀÚ ÇǺΠÀ̽ÄÀÇ Çʿ伺À» ÁÙÀ̰í ÇÕº´Áõ°ú ȸº¹ ½Ã°£À» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Á¶Á÷°øÇÐ ÇǺΠ´ëü¹° ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

Á¶Á÷°øÇÐ ÇǺΠ´ëü¹° ½ÃÀåÀÇ ¼ºÀåÀº È­»ó ¹× ¸¸¼º »óóÀÇ ¹ßº´·ü Áõ°¡, Á¶Á÷°øÇÐÀÇ ¹ßÀü, ´õ ³ªÀº »óó Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. »ýü°øÇÐÀû ½ºÄ³Æúµù, ¼ºÀåÀÎÀÚ ÁÖÀÔ ´ëüÀç, õ¿¬ Á¶Á÷°úÀÇ ÅëÇÕ¼º Çâ»ó µîÀÇ Çõ½ÅÀ¸·Î ÀÎÇØ ÇコÄɾî Àü¹Ý¿¡ °ÉÃÄ Àû¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ȯÀÚ ¿¹ÈÄ °³¼±, ȸº¹ ½Ã°£ ´ÜÃà, ÀÔ¿ø ±â°£ ÃÖ¼ÒÈ­¿¡ ÁßÁ¡À» µÐ Á¶Á÷°øÇÐ ÇǺΠ´ëü¹°Àº »óó °ü¸®¿¡ Áß¿äÇÑ ÀÌÁ¡À» Á¦°øÇÔÀ¸·Î½á ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·áºñ ÁöÃâ Áõ°¡, ÷´Ü »óó Ä¡·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Àç»ýÀÇ·á¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ Á¶Á÷°øÇÐ ÇǺΠ´ëü¹°ÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(»ý¹°ÇÐÀû, ÇÕ¼º, »ýÇÕ¼º);ÃÖÁ¾ ¿ëµµ(±Þ¼º±â, ¸¸¼º±â);ÃÖÁ¾»ç¿ëÀÚ(º´¿ø, â»ó Ä¡·á ¼¾ÅÍ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 33»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Tissue Engineered Skin Substitutes Market to Reach US$5.4 Billion by 2030

The global market for Tissue Engineered Skin Substitutes estimated at US$3.1 Billion in the year 2023, is expected to reach US$5.4 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2023-2030. Biological Substitutes, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$2.9 Billion by the end of the analysis period. Growth in the Synthetic Substitutes segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$853.0 Million While China is Forecast to Grow at 7.6% CAGR

The Tissue Engineered Skin Substitutes market in the U.S. is estimated at US$853.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$822.5 Million by the year 2030 trailing a CAGR of 7.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.6% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Global Tissue Engineered Skin Substitutes Market - Key Trends and Drivers Summarized

How Are Tissue Engineered Skin Substitutes Revolutionizing Wound Care?

Tissue engineered skin substitutes are advanced biomaterials designed to replace damaged or lost skin tissues in patients suffering from severe burns, chronic wounds, and other skin injuries. These substitutes are developed using biocompatible scaffolds, cells, and growth factors to mimic the structure and function of natural skin, promoting faster healing and reducing scarring. Available as allogeneic, autologous, and xenogeneic grafts, tissue engineered skin substitutes provide vital solutions in reconstructive surgery, dermatology, and wound management. As healthcare systems emphasize better patient outcomes and faster recovery, tissue engineered skin substitutes have gained traction as effective alternatives to traditional skin grafts.

What Are the Key Segments in the Tissue Engineered Skin Substitutes Market?

Major product types include acellular, cellular, and composite substitutes. Acellular substitutes, made primarily from collagen or other biomaterials, hold a significant share due to their wide use in burn treatments and chronic wound management. Cellular substitutes, which contain living cells, are gaining popularity for their ability to integrate with the patient’s skin and enhance healing. Applications of tissue engineered skin substitutes cover burn management, diabetic ulcers, pressure ulcers, and reconstructive surgeries, with burn management representing the largest segment due to the critical need for rapid skin regeneration in severe cases. End-users of tissue engineered skin substitutes include hospitals, wound care centers, and specialty clinics. Hospitals lead the market, utilizing these substitutes for burn treatments, reconstructive surgeries, and chronic wound management, where rapid healing and reduced hospitalization are critical. Wound care centers use skin substitutes for treating diabetic ulcers, pressure sores, and other non-healing wounds, improving patient recovery and reducing the risk of infection. Additionally, specialty clinics employ these substitutes in cosmetic and reconstructive surgeries, ensuring better aesthetic outcomes and faster recovery times.

How Are Tissue Engineered Skin Substitutes Applied in Healthcare?

In hospitals, tissue engineered skin substitutes are used to treat severe burns, deep wounds, and post-surgical recovery, promoting faster healing and minimizing scar formation. In wound care centers, these substitutes play a critical role in managing chronic wounds like diabetic ulcers and pressure sores, where they help regenerate skin tissues and prevent infections. In reconstructive and cosmetic surgeries, skin substitutes provide aesthetic restoration and improved skin function, particularly in cases of trauma, congenital defects, and post-cancer surgeries. The use of advanced biomaterials in these substitutes also reduces the need for donor skin grafts, minimizing complications and recovery times.

What Factors Are Driving the Growth in the Tissue Engineered Skin Substitutes Market?

The growth in the Tissue Engineered Skin Substitutes market is driven by several factors, including rising incidence of burns and chronic wounds, advancements in tissue engineering, and increasing demand for better wound care solutions. Innovations like bioengineered scaffolds, growth factor-infused substitutes, and improved integration with natural tissues have expanded their applications across healthcare. The focus on improving patient outcomes, reducing recovery times, and minimizing hospital stays has further fueled demand, as tissue engineered skin substitutes offer critical benefits in wound management. Additionally, growing healthcare spending, rising awareness of advanced wound care treatments, and increased investment in regenerative medicine have contributed to market growth, encouraging the adoption of tissue engineered skin substitutes in diverse medical settings.

SCOPE OF STUDY:

The report analyzes the Tissue Engineered Skin Substitutes market in terms of US$ Thousand by the following Application; End-Use; Product, and Geographic Regions/Countries:

Segments:

Product (Biological, Synthetic, Biosynthetic); Application (Acute, Chronic); End-Use (Hospitals, Wound Care Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â